Meihua International Medical Technologies Co., Ltd. announced the appointments of Mr. Xin Wang as Chief Executive Officer and director and Ms. Huijuan Zhao as independent board member, member of compensation committee and audit committee, and chair of nominating committee, effective as of December 1st, 2022, to fill the vacancies arising from the voluntary resignations of Mr. Yulin Wang as CEO, interim CFO and director of the Company due to the expiration of his employment contract, and Mr. Xu Han as independent board member, member of compensation committee and audit committee, and chair of nominating committee, who resigned for personal reasons. Prior to joining MHUA, from 2021 until 2022, Mr. Xin Wang was CEO of the Jiangsu Yada Technology Group Co., Ltd., a PRC company that develops and distributes medical devices. In addition, Mr. Wang served as Vice General Manager of Shanghai New Asia (Group) Co., Ltd., a pharmaceutical company, where he led production management, market expansion, research and development of proprietary Chinese traditional medicines from 2020 to 2021.

From 2018 to 2020, Mr. Wang held key position at Panda Group Inc., a franchise restaurant corporation based in California, where he was in charge of large commercial projects related to expanding its business operations and upgrading its brand strategy in the US market. In addition, Mr. Wang worked as a financial analyst at Morgan Stanley and area manager at Citibank, N.A., thus providing him insight into global investment banking and US financial markets. Mr. Wang obtained his bachelor's degree from the University of California Santa Barbara, where he double majored in Financial Mathematics & Statistics Analysis and Computer Science.

He also obtained his master's degree in Actuarial Science in 2012 from UC Santa Barbara. Ms. Huijuan Zhao served as a member of the management team at Ping'An Bank, where she oversaw services for high net wealth clients and risk control practices from 2019 to 2022. In her prior role as head of marketing and risk control operations at two Jiangsu-based privately owned businesses operating in business and financial service sectors from 2013 to 2019,  Ms. Zhao helped build out market expansion and risk control protocols and playbook and played critical supervisory and coaching roles to the growth and expansion of both businesses.

She holds a bachelor's degree in Financial English from Suzhou University, which she received in 2012. Ms. Zhao, our independent director, and Mr. Zhao, our CFO, are not related.